Clinical trial
Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies
NCT06586177
Study timeline
Study start (actual)2021-10-27Date precision: day
Registry last updated2025-09-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing-remitting Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Heinrich-Heine University, Duesseldorflead sponsor
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06586177 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.